Home / Resources (page 567)

Resources

RESOURCES

The Expansion of the SGLT-2 Inhibitor Market

What’s New on the Horizon? Heather Good, Doctor of Pharmacy, Candidate University of Florida Sodium-glucose co-transporter 2 (SGLT2) inhibitors, the first drugs to actually eliminate glucose from the body, are paving the way for a new wave of diabetes treatment options. Canagliflozin (Invokana®) took the U.S. market by storm when …

Read More »

ADA/JDRF Type 1 Diabetes Sourcebook, Excerpt #17: Insulin, Part 2 of 3

T1-diabetes-sourcebook

Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor PEDIATRICS – Jane Lee Chiang, MD, and Georgeanna J. Klingensmith, MD ADULTS – Irl B. Hirsch, MD 1. Basal insulin accounts for ~50% of total daily dose: i. LAA (insulin glargine, detemir, degludec) or NPH if LAA …

Read More »

Medic Shoes

medicshoesimage

Medic Shoes  Medic Shoes™ are for people who suffer from diabetes-induced leg pain and circulatory problems. These comfortable shoes enhance peripheral circulation and increase blood flow, alleviating symptoms of poor peripheral circulation and neuropathy, including foot pain, burning, cramping, and tingling. The shoes can provide instant relief to these side effects, leading …

Read More »

Risk Factors for Hypoglycemia and Strategies for Avoidance

Minimizing hypoglycemia in type 2 diabetes patients…. Hypoglycemia is a common problem among patients taking combinations of insulin and sulfonylureas and may be a limiting factor in diabetes therapy management. Hypoglycemia is defined by the American Diabetes Association (ADA) as a plasma glucose of 79mg/dL. (3.9mmol/L) or less; however most people …

Read More »